Finance
Surgical product company completes equity placement
Published in Cancer Weekly, December 23rd, 2003
The purchasers included both institutional investors and high net worth individuals. In the placement, 12.2 million shares of common stock were issued at $0.23 per share, as well as Series R warrants to purchase additional 6.1 million common shares at $0.28 per share. The warrants have a term of five years. The company has agreed to file a registration statement covering resales of the securities by the purchasers to the public no later than December 31, 2003.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-12-23)
More Articles from Cancer Weekly
- Larynx Cancer
New standard for voice-saving care of patients introduced - Multiple Myeloma
Origin of bone marrow cancer found in rare stem cell - Colorectal Cancer
Calcium and vitamin D collaborate to reduce risk - Gene Therapy
CD46 acts as cellular receptor for group B adenoviruses - Prostate Cancer
Gene therapy and radiation combination shows promise in prostate cancer study - Antifungal Therapy
Pediatric patients may benefit from voriconazole for invasive aspergillosis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
